查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1375995

初級保健 POC 診斷市場規模、佔有率、趨勢分析報告：按產品、最終用途、地區和細分市場分類的趨勢，2023-2030 年

Primary Care POC Diagnostics Market Size, Share & Trends Analysis Report By Product (Glucose Testing, Lipid Testing, Drug Abuse Testing), By End-use (Pharmacy & Retail Clinics, Physician Office), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 192 Pages | 商品交期: 2-10個工作天內

價格

初級保健 POC 診斷市場成長和趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球初級保健POC診斷市場規模預計將達到261.7億美元，預測期內年複合成長率為6.5%。

我們靈活且先進的核心分子實驗室支援並支援使用 POC 測試，將許多常見目標的篩檢轉移到醫院接待室和醫生辦公室。

根據《美國臨床病理學雜誌》2014 年進行的一項研究，POC 檢測的效果優於製造商，患者的隨訪電話和信件分別減少了 85.0% 和 89.0%，隨訪減少了 61.0%。被發現可以改善臨床業務。此外，測試訂單數量下降了21.0%。

此外，根據 1988 年臨床實驗室改進法案 (CLIA) 獲得豁免狀態的檢測數量不斷增加預計將推動市場成長。由於每位患者的成本節省約 12-15 美元，後續檢測減少約 50.0%，研究機構和製造商擴大推薦這些檢測。然而，不同的測試方法及其使用領域之間存在顯著的重疊。例如，血糖檢測板和快速國際標準化比率測試最初用於自我測試，現在已在醫院和初級機構中使用。

初級保健 POC 診斷市場報告亮點

  • 2022年，由於感染疾病不斷上升、對快速準確診斷的需求以及對POC檢測益處的認知不斷增強，感染疾病行業佔據最大的市場佔有率，達到26.4%。
  • 將血脂檢測作為常規檢查一部分的門診診所的增加，預計將積極提高血脂檢測在市場上的採用率，並使其在整個市場的產品中佔據顯著地位。
  • 就最終用途而言，研究機構和生物技術公司對先進、更準確的 POC檢測套組的合作探索可能會推動醫生辦公室領域的發展，而政府擴大初級保健設施的舉措和計劃預計將推動非診所領域的發展診所部分。
  • 北美的初級保健 POC 診斷市場比世界其他地區更加發達。該地區的發展得益於多種創新和先進的 POC 診斷產品的推出，以及初級家庭醫療保健和輔助醫學中對 POC 診斷的認知和需求的不斷成長。
  • 美國市場的患者擴大參與居家醫療、家庭測試和監測設備。此外，基於網路的數位化、電子病歷、遠端醫療和監測資料解決方案在美國正在加速發展並推動成長。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 初級保健 POC 診斷市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 初級保健 POC 診斷市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 初級保健 POC 診斷：產品估算/趨勢分析

  • 初級保健 POC 診斷市場：要點
  • 初級保健 POC 診斷市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 血糖測試
    • 2018年至2030年血糖檢測市場估計與預測
  • Hb1Ac 測試
    • 2018 年至 2030 年 Hb1Ac 檢測市場估計與預測
  • 自體免疫疾病
    • 2018年至2030年自體免疫疾病市場估計與預測
  • 凝固
    • 2018年至2030年混凝市場估計與預測
  • 生育力
    • 2018年至2030年不孕市場估計與預測
  • 感染疾病
    • 2018年至2030年感染疾病市場估計與預測
  • 心臟標記
    • 2018年至2030年心臟標記物市場估計與預測
  • 甲狀腺刺激素
    • 2018年至2030年甲狀腺刺激素市場估計與預測
  • 血液學
    • 2018年至2030年血液學市場估計與預測
  • 初級保健系統
    • 2018年至2030年初級保健系統市場估計與預測
  • 分散式臨床化學
    • 2018年至2030年分散式臨床化學市場估計與預測
  • 屎
    • 2018年至2030年糞便市場估計與預測
  • 血脂測試
    • 2018年至2030年血脂檢測市場估計與預測
  • 癌症標記物
    • 2018年至2030年癌症標記物市場估計與預測
  • 血氣/電解質
    • 2018 年至 2030 年血氣/電解質市場估計與預測
  • 門診化學
    • 2018年至2030年門診化學品市場估計與預測
  • 藥物濫用測試
    • 2018年至2030年藥物濫用檢測市場估計與預測
  • 尿液檢查
    • 2018年至2030年尿液檢查市場估計與預測

第5章 初級保健 POC 診斷：最終用途估計和趨勢分析

  • 初級保健 POC 診斷市場：要點
  • 初級保健 POC 診斷市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 藥房和零售診所
  • 診所
  • 緊急醫療診所
  • 非醫療診所

第6章 初級保健POC診斷市場：區域估計與趨勢分析

  • 區域展望
  • 按地區分類的初級保健 POC 診斷市場：主要市場點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • F Hoffmann-La Roche Ltd.
    • Danaher
    • Abbott
    • Siemens Healthineers
    • bioMerieux SA
    • Abaxis
    • QIAGEN
    • Johnson & Johnson Services, Inc.
    • Nova Biomedical
    • Instrumentation Laboratory
    • Trividia Health, Inc.
    • OraSure Technologies, Inc.
    • Quidel Corporation
    • Trinity Biotech
    • Sekisui Diagnostics
    • BD
Product Code: GVR-2-68038-333-1

Primary Care POC Diagnostics Market Growth & Trends:

The global primary care POC diagnostics market size is expected to reach USD 26.17 billion by 2030, according to a new report by Grand View Research, Inc.., registering a 6.5% CAGR during the forecast period. Flexible and forward-thinking core molecular labs have been embracing and supporting the use of POC tests to move screening of many common targets to hospital receiving rooms and physicians' offices.

As per a study conducted by the American Journal of Clinical Pathology in 2014, it was found that POC testing improved clinical operations for manufacturers by reducing follow-up calls and letters of patients by 85.0% and 89.0%, respectively, and reducing their follow-up visits by 61.0%. It was also observed that the number of tests ordered decreased by 21.0%.

Furthermore, rise in the number of tests receiving a waived status under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) is anticipated to aid market growth. Researchers and manufacturers are increasingly recommending these tests owing to cost reduction of about USD 12-15 per patient and reduction in follow up tests by about 50.0%. However, there is a massive overlap between different methods and their areas of usage. For instance, panels to measure glucose and quick international normalized ratio tests were originally meant for self-testing but are now used in hospitals and primary settings instead.

Primary Care POC Diagnostics Market Report Highlights:

  • The infectious disease segment held the largest market share at 26.4% in 2022, owing to the increased prevalence of infectious diseases, demand for quick and precise diagnosis, and the growing awareness of the benefits of POC testing.
  • Increase in out-patient practices for lipid testing as part of a routine checkup is expected to positively enhance the adoption rate of lipid testing in the market, giving it a prominent spot in the overall market by product
  • In terms of end use, while collaborative research for advanced and more accurate POC testing kits by research institutes and biotech firms is likely to facilitate the physicians' office segment, government initiatives and projects to extend primary care facilities will boost the non-practice clinics segment
  • The North America primary care POC diagnostics market is more developed compared to the rest of the world. The regional segment is fueled by availability of several innovative and advanced POC diagnostic products and growing awareness and demand for point-of-care diagnostics in primary home healthcare and assisted healthcare
  • The U.S. market is witnessing a shift toward increasing patient involvement in home care, home-based tests, and monitoring instruments. In addition, digitalization, EHR, telemedicine, and web-enabled solutions of monitoring data are gaining pace in U.S., thereby driving its growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. End use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Primary Care POC Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Primary Care POC Diagnostics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Primary Care POC Diagnostics: Product Estimates & Trend Analysis

  • 4.1. Primary Care POC Diagnostics Market: Key Takeaways
  • 4.2. Primary Care POC Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Glucose Testing
    • 4.3.1. Glucose Testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Hb1Ac Testing
    • 4.4.1. Hb1Ac testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. 4.5. Autoimmune Disease
    • 4.5.1. Autoimmune Disease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Coagulation
    • 4.6.1. Coagulation market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Fertility
    • 4.7.1. Fertility market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Infectious Diseases
    • 4.8.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Cardiac Markers
    • 4.9.1. Cardiac markers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.10. Thyroid Stimulating Hormone
    • 4.10.1. Thyroid stimulating hormone market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.11. Hematology
    • 4.11.1. Hematology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.12. Primary Care Systems
    • 4.12.1. Primary care systems market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.13. Decentralized Clinical Chemistry
    • 4.13.1. Decentralized clinical chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.14. Feces
    • 4.14.1. Feces market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.15. Lipid Testing
    • 4.15.1. Lipid testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.16. Cancer Markers
    • 4.16.1. Cancer markers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.17. Blood Gas/Electrolytes
    • 4.17.1. Blood gas/electrolytes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.18. Ambulatory Chemistry
    • 4.18.1. Ambulatory chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.19. Drug Abuse Testing
    • 4.19.1. Drug abuse testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.20. Urinalysis
    • 4.20.1. Urinalysis market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Primary Care POC Diagnostics: End Use Estimates & Trend Analysis

  • 5.1. Primary Care POC Diagnostics Market: Key Takeaways
  • 5.2. Primary Care POC Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Pharmacy & Retail Clinics
    • 5.3.1. Pharmacy & Retail Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Physician office
    • 5.4.1. Physician office market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Urgent Care Clinics
    • 5.5.1. Urgent care clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Non-practice Clinics
    • 5.6.1. Non-practice clinics market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Primary Care POC Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Primary Care POC Diagnostics Market by Region: Key Marketplace Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. F Hoffmann-La Roche Ltd.
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Danaher
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Abbott
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Siemens Healthineers
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. bioMerieux SA
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Abaxis
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. QIAGEN
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Johnson & Johnson Services, Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Nova Biomedical
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Instrumentation Laboratory
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Trividia Health, Inc.
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. OraSure Technologies, Inc.
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. Quidel Corporation
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. Trinity Biotech
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives
    • 7.2.15. Sekisui Diagnostics
      • 7.2.15.1. Company overview
      • 7.2.15.2. Financial performance
      • 7.2.15.3. Product benchmarking
      • 7.2.15.4. Strategic initiatives
    • 7.2.16. BD
      • 7.2.16.1. Company overview
      • 7.2.16.2. Financial performance
      • 7.2.16.3. Product benchmarking
      • 7.2.16.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 4 North America primary care POC diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 10 Europe primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe primary care POC diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 13 Germany primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 14 UK primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 15 UK primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 16 France primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 17 France primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Italy primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 19 Italy primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Spain primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 21 Spain primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Sweden primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 23 Sweden primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Norway primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 25 Norway primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Denmark primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 27 Denmark primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific primary care POC diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 31 China primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 32 China primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Japan primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 34 Japan primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 35 India primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 36 India primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Australia primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 38 Australia primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Thailand primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 40 Thailand primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 41 South Korea primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 42 South Korea primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 44 Latin America primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Latin America primary care POC diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 47 Brazil primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Mexico primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 49 Mexico primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Argentina primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 51 Argentina primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa primary care POC diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 56 South Africa primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 59 UAE primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 60 UAE primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Primary care POC diagnostics: Market outlook
  • Fig. 9 Primary care POC diagnostics: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Primary care POC diagnostics market driver impact
  • Fig. 15 Primary care POC diagnostics market restraint impact
  • Fig. 16 Primary care POC diagnostics market strategic initiatives analysis
  • Fig. 17 Primary care POC diagnostics market: Product movement analysis
  • Fig. 18 Primary care POC diagnostics market: Product outlook and key takeaways
  • Fig. 19 Glucose testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Hb1Ac testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Autoimmune disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Coagulation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Fertility market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Infectious diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Cardiac markers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Thyroid stimulating hormone market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Hematology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Primary care systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Decentralized clinical chemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Feces market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Lipid testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Cancer Marker market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Blood gas/electrolytes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Ambulatory chemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Drug abuse testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Urinalysis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Primary care POC diagnostics market: End use movement analysis
  • Fig. 38 Primary care POC diagnostics market: End use outlook and key takeaways
  • Fig. 39 Pharmacy & retail clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Physician office market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Urgent care clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Non-practice clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Global primary care POC diagnostics market: Regional movement analysis
  • Fig. 44 Global primary care POC diagnostics market: Regional outlook and key takeaways
  • Fig. 45 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)